1 | Tozadenant | [1] Tozadenant Tozadenant (Tozadenant) | [1] Tozadenant
Tozadenant
(Tozadenant) 💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
2 | Tozadenant (SYN115) 120 MG BID | [1] Tozadenant Tozadenant (Tozadenant) | [1] Tozadenant
Tozadenant
(Tozadenant) 💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
3 | Tozadenant (SYN115) 180 MG BID | [1] Tozadenant Tozadenant (Tozadenant) | [1] Tozadenant
Tozadenant
(Tozadenant) 💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
4 | Tozadenant (SYN115) 240 MG BID | [1] Tozadenant Tozadenant (Tozadenant) | [1] Tozadenant
Tozadenant
(Tozadenant) 💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|
5 | Tozadenant (SYN115) 60 MG BID | [1] Tozadenant Tozadenant (Tozadenant) | [1] Tozadenant
Tozadenant
(Tozadenant) 💬
| [1] ADORA2A ADORA2A 💬
| [8] Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1] 6 6 💬
|